The first mutation associated with hypertrophic cardiomyopathy (HCM) is the R403Q mutation in the gene encoding β-myosin heavy chain (β-MyHC). R403Q locates in the globular head of myosin (S1), responsible for interaction with actin, and thus motor function of myosin. Increased cross-bridge relaxation kinetics caused by the R403Q mutation might underlie increased energetic cost of tension generation; however, direct evidence is absent. Here we studied to what extent cross-bridge kinetics and energetics are related in single cardiac myofibrils and multicellular cardiac muscle strips of 3 HCM patients with the R403Q mutation and 9 sarcomere mutation-negative HCM patients (HCM smn ). Expression of R403Q was on average 41±4 % of total MYH7 mRNA. Cross-bridge slow relaxation kinetics in single R403Q myofibrils was significantly higher (P<0.0001) compared to HCM smn myofibrils (0.47±0.02 and 0.30±0.02 s -1 , respectively). Moreover, compared to HCM smn tension cost (TC) was significantly higher in the muscle strips of the 3 R403Q patients (2.93±0.25 and
Introduction
Familial hypertrophic cardiomyopathy (HCM) is an inherited cardiac disease with an incidence of 1:500. It is most frequently caused by mutations in genes encoding sarcomeric proteins. 1 The first identified mutation (R403Q) is located in the gene (MYH7) encoding cardiac β-myosin heavy chain and has been associated with high penetrance and a severe clinical phenotype. This malignant MYH7 mutation results in a conversion of a highly conserved arginine residue to a glutamine 2 at position 403 in the globular head of myosin (subfragment 1, S1). Based on the location of residue 403 at the base of a surface loop known to directly interact with actin it is most likely that the R403Q mutation directly interferes with motor and sarcomere function. 3, 4 A previous study in myofibrils from a HCM patient harboring the R403Q mutation revealed faster generation and relaxation rates of tension development compared to healthy controls. 5 In the 2-state model of actin-myosin interactions 6 the rate of force redevelopment (k tr ) in myofibrils is equal to
in which f app and g app represent the apparent rate constants of the transition of the cross-bridges into the force-generating states and back into the non-force generating states, respectively. K tr can be derived from quick tension recovery after a short period of unloaded shortening or from the time course of force development (k act ) as can be measured in myofibrils. 5, 7 The relaxation of myofibrils is characterized by a slow, linear relaxation phase (slow k rel ) and a fast exponential relaxation component (fast k rel ). It has been shown that the isometric slow k rel is equal to g app because at low [Ca 2+ ] cross-bridges strongly bound cross-bridges leave the force-generating states upon ADPrelease and ATP-rebinding whereas weakly-bound cross-bridges are unable to go into the force-generating states. . [6] [7] [8] [9] Moreover, g app is equivalent to the energetic cost of tension generation or the ratio of ATPase activity over force, TC=ATPase activity/Force (Supplementary material). 6, 10, 11 The human myofibrils with the R403Q mutation showed a lower maximal tension, a 2-fold increase in k act and a 3-fold increase in slow k rel compared to non-failing donor myofibrils. 5 The prominent enhancement of relaxation kinetics is indicative for increased energetic cost of tension generation, and may be central in the pathogenesis of HCM caused by the R403Q mutation. However, direct demonstration that high cross-bridge detachment kinetics under isometric conditions of contraction caused by the R403Q mutation underlies increased energetic cost of tension generation (TC) is absent. Therefore, we extended the previous observations by investigating if TC is increased in cardiac samples from 3 different HCM patients harboring the R403Q mutation and how this correlates to slow relaxation kinetics. We simultaneously measured isometric force development and ATPase activity in cardiac muscle strips, providing a direct measure of TC at the level of the sarcomere. Cross-bridge kinetics was assessed during force measurements in myofibrils isolated from the same samples. R403Q samples were compared with cardiac tissue of 8 sarcomere mutation-negative patients HCM patients. The HCM smn patients present with the same clinical phenotype as the R403Q patients and underwent cardiac surgery under similar conditions, which makes them a very representative reference group.
Methods

Ethical approval
The study protocol is in line with the principles outlined in the Declaration of Helsinki and was approved by the local Ethics Committees. Written informed consent was obtained at the involved medical centres (Erasmus Medical Centre, Rotterdam, The Netherlands; Brigham and Women's Hospital, Cardiology, Boston, USA and the Careggi University Hospital, Florence, Italy)
Cardiac tissue
Interventricular tissue was obtained from 10 HCM patients during myectomy surgery to relieve left ventricular (LV) outflow tract obstruction, and LV-tissue from 2 HCM patients was obtained during heart transplantation (HT) surgery. The tissue was snapfrozen in liquid nitrogen. Three patients harbored the MYH7 R403Q mutation (1 myectomy, R403Q(1) and 2 HT, R403Q(2) and R403Q(3)), while 9 sarcomere mutation-negative HCM patients (myectomies) served as control (HCM smn ; no identified sarcomeric gene mutation after screening of 8 HCM-associated genes 12 ). Patient characteristics are shown in Table 1 .
Manifest HCM was evident from the high septal thickness (normal value <13 mm) 13 and high LV outflow tract pressure gradient (normal value <30 mm Hg). 14 Multicellular cardiac muscle strips were isolated from 3 R403Q and 5 HCM smn patients. In addition, cardiac myofibril preparations were isolated from the same 3 R403Q patients and 3 HCM smn patients. Data of HCM smn multicellular muscle strips 15 and myofibril data from patient R403Q(1) have been published previously.
5 Table 1. Patient characteristics  Patient  Age, y  Sex  LVOT  ST  HCM R403Q  R403Q(1)  24  M  85  34  R403Q(2)  35  M  HT  HT  R403Q(3)  59  F  HT  HT  HCM smn  1  35  M  76  30  2  54  M  100  33  3  42  M  75  26  4  52  M  169  22  5  65  F  85  19  6  72  F  88  24  7  49  M  61  20  8  46  M  81  19  9  59  M  85  18  M, male; F, female; LVOT, left ventricular outflow tract pressure gradient in mmHg; ST, septal thickness in mm; HT, heart transplantation.
Sarcomere energetics in multicellular muscle strips
All muscle strips were immersed in cold relaxing solution (pH 7.0; in mmol/l: free Mg 2+ 1, KCL 145, EGTA 2, ATP 4, imidazole 10) and cut parallel to the long axis of the fibers in cold relaxing solution to minimize damage. Subsequently, muscle strips were permeabilized overnight in relaxing solution with 1% Triton X-100 at 4°C, which allowed us to control the intracellular Ca 2 concentration during measurements without interference of Ca 2+ -handling proteins.
The experimental procedures, solutions and equipment used for functional measurements were as described previously. 15, 16 The length of the preparations was adjusted on the basis of passive tension by stretching them until a level of 1-2 kN/m 2 was reached, which corresponds to a sarcomere length of about 2.2 μm. 17 The dimensions (mean±S.E.M) of the ventricular muscle strips were 1.52±0.09 mm in length, 368±12 μm in width and 330±9 μm in depth (no significant differences between groups). Isometric force and ATPase activity were measured at maximal and submaximal [Ca 2+ ] at 20°C. During the measurement the muscle strips were kept inside a small chamber with a volume of 30 μl with thin quartz windows. Original registrations of force development and ATPase activity are shown in Figure 1A -D. Maximal force was determined after the force signal reached a plateau and normalized to the cross-sectional area (CSA) of the muscle strip to calculate tension (force/CSA) ( Figure 1A&B ). The CSA of the preparation was estimated in the set-up assuming an elliptical shape, i.e. CSA= (width x depth x π)/4. ATPase activity, was measured using an enzyme coupled assay. In this assay the ATP regeneration from ADP and phosphoenol-pyruvate, catalyzed by the enzyme pyruvate kinase, is coupled to the oxidation of NADH to NAD + and the reduction of pyruvate to lactate, catalyzed by L-lactic dehydrogenase. NADH oxidation was measured photometrically from the absorbance at 340 nm of near-UV light. The absorbance signal was calibrated by adding 0.5 nmol of ADP (arrow) to the solution in the measuring chamber. Using this calibration, ATPase activity in the muscle strip could be derived from the slope of the absorbance signal ( Figure 1C&D ). The maximal Ca
2+
-activated ATPase activity was calculated by subtracting resting ATPase activity (measured in relaxing solution) from the maximal NADH oxidation and normalization to the volume of the muscle strip. The economy of muscle contraction is expressed as TC, i.e. ATPase activity during force development (ATPase activity/tension).
Cross-bridge kinetics in myofibril preparations
Thin strips of the patient cardiac samples were incubated overnight in ice-cold relaxing solution (pCa 8.0, pH 7.0, in mmol/L: ionic strength 200, EGTA 10, TRIS 10, MgATP 5, free Mg 2+ 1) added with 1% Triton X-100. Triton was then removed and the strips were homogenized in the same relaxing solution to produce myofibril suspensions that were stored at 0-4°C and used for experiments for up to 4 days. Techniques for mechanical measurements in human cardiac myofibrils were as previously described. 5, 10, 18 Briefly, myofibrils were transferred to a temperature controlled chamber filled with relaxing solution (pCa 8.0, 15°C). The selected myofibril was mounted (initial sarcomere length around 2.2 µm) between a cantilever force probe and a glass needle mounted on the shaft of a length control motor. Myofibrils were maximally activated and fully relaxed by rapid solution switching between 2 continuous streams of solutions (pCa 8.0 and 4.5) (Figure 1 E-H). All solutions contained an MgATP-regenerating system and a cocktail of protease inhibitors. Slow k rel is estimated from the slope of the regression line fitted to the tension trace normalized to the entire amplitude of the tension relaxation transient. The rate constant for fast k rel is estimated from a mono-exponential fit.
Histology
Of each R403Q patient and 3 HCM smn patients 10 myocardial cryosections of 5 µm were formalin fixed. 
Allelic mRNA expression analysis
RNA was extracted from 40 mg frozen cardiac tissue using the PeqGold Total RNA Kit (PeqLab) according to the supplier's protocol. RNA integrity was analysed using the BioAnalyzer (PicoKit, Agilent) and revealed a RNA integrity number above 6 for all patient samples. For the reverse transcription 2 µl RNA were incubated with 1x reaction buffer, 2.5 mmol dNTPs each, 8 pmol MYH7 specific primer (5'-GCCTTGCCTTTGCCCTTCTCA-3'), 20 U RiboSafe (Bioline), and 100 U Tetro RT (Bioline) in 20 µl for 1 h at 42°C. For qPCR 1x reaction buffer S (Hot Taq DNA Polymerase, PeqLab, Germany), 25 mmol dNTPs each, 10 pmol forward primer (5'-TGACAGGCGCCATCATGCACTTTGGA-3'), 10 pmol reverse primer (5'-CTGCTTGGTCTCCAGGGTGGCA-3'), 1.25 mmol MgCl 2 , 1 U Hot Taq DNA Polymerase (PeqLab) in a final volume of 25 µl were applied to an initial denaturation at 95°C for 5 min, 25 cycles of denaturation at 95°C for 30 sec, annealing at 70°C for 30 sec, elongation at 72°C for 30 sec, and a final elongation step at 72°C for 2 min. To eliminate heteroduplexes we performed a reconditioning PCR as described previously. 19 In brief, the PCR products were diluted 1:100 and applied to 8 parallel PCR reactions that were terminated in the linear phase of the PCR. The reactions were pooled, precipitated and subjected to a mutation specific DdeI treatment by adding 1x buffer 4 and 10 U DdeI (NEB) to a final volume of 10 µl and incubation at 37°C for at least 3 h or over night. The treatment yielded a fragment of 119 basepairs (bp) for both alleles, a wildtype specific fragment of 180 bps and a mutation specific fragment of 148 bp. The fragments were separated in 2.5 % sieving agarose gels (Biozym) stained with ethidium bromide and quantified as described for other MYH7 mutations 19 , In brief, the integrated optical density was determined for each band and normalized for the respective size. The fraction of each allele was calculated as the percentage from the common 119 bp band.
Statistical analysis
Data analysis and statistics were performed using Prism version 5.0 (Graphpad Software, Inc., La Jolla, CA) and SPSS version 20.0 (IMB, Armonk, NY, USA). The data are presented as mean±S.E.M. The statistics regarding functional measurements are based on the individual myofibril preparations and multicellular muscle strips. Using the Shapiro-Wilk test the data sets were analyzed whether the assumption of normality was not violated. Normality was assumed when P>0.05 and the variances were equal. As the repeated samples assessments had to be taken into account (multiple myofibril preparations and muscle strips were measured from one patient), multilevel analysis was performed using a linear mixed model procedure to investigate differences between the groups as published previously. [20] [21] [22] For this purpose, the data sets violating the normality assumption (P<0.05) were logarithmically transformed. The histological data was analyzed with the non-parametric ] increase of the HCM smn and R403Q(1) myofibril preparations shown in E. and F. superimposed on a faster time base after normalization for maximal tension. H. Tension relaxation kinetics following sudden Ca 2+ removal of the HCM smn and R403Q(1) myofibril preparations superimposed on a faster time base after normalization for maximal tension. k act is the rate constant of tension generation and k rel represents the rate constant of relaxation.
Results
Sarcomere energetics
Simultaneous measurements of force generation and ATPase activity were performed in membrane-permeabilized muscle strips from 3 R403Q patients and 5 HCM smn patients. The normality assumption was not violated by any of the datasets (P>0.05). 95% confidence intervals are provided in Supplementary Table 1 .
Maximal tension (force normalized by CSA) on average was significantly lower (11.4±1.1 kN/m 2 ) in the R403Q muscle strips compared with HCM smn (24.4±1.6 kN/m 2 , Figure   2A ). The muscle strips from each individual patient showed a significant decrease in maximal tension compared with HCM smn as well ( Figure 2B ). Maximal ATPase activity, corrected for resting ATPase activity (4.4±0.5 and 6.6±1.2 μmol•L -1 •s -1 , respectively), was significantly lower Figure 2C ). When the muscle strips were separated per patient, both R403Q(1) and R403Q(3) muscle strips showed a significantly lower maximal ATPase activity compared with HCM smn . In addition, R403Q(1) had a significantly lower ATPase activity compared with R403Q(2) ( Figure 2D ). Maximal TC was calculated by dividing maximal ATPase activity by maximal tension. TC ( Figure 2E ) was significantly higher in R403Q compared with HCM smn (2.9±0.2 and
, respectively). In addition, maximal TC of R403Q(1) was significantly higher than HCM smn and higher compared with R403Q(2) and R403Q(3) ( Figure  2F ). Additional measurements of force and ATPase activity were performed at submaximal [Ca 2+ ] in a subset of muscle strips. Figure 3A shows tension development and corresponding ATPase activity of the R403Q and HCM smn muscle strips (not corrected for basal ATPase activity) over a range of [Ca 2+ ]. The relation between tension and ATPase activity over the entire [Ca 2+ ] range can be estimated by a linear equation as shown previously. 23 The slopes of the tension-ATPase activity relations represent TC over the entire
]. The slopes of the R403Q muscle strips are significantly higher compared with HCM smn ( Figure 3A) . When plotting the average curves per R403Q patient, the R403Q(1) showed a significantly higher slope compared with HCM smn and R403Q(3) ( Figure 3B ). 95% confidence intervals regarding each significant difference are provided in Supplementary (1) 
Cross-bridge kinetics
The parameters of cross-bridge kinetics were measured in myofibril preparations of the 3 HCM patients with the R403Q mutation and of 3 HCM smn . Data regarding R403Q(1) has been previously published 5 , however measuring more myofibrils of this patient was not possible because the remaining preserved myectomy tissue has been used for TC measurements in multicellular muscle strip, histological analyses and mRNA analysis. Representative contraction-relaxation traces of myofibril preparations are shown in Figure 1E -H. Both k act and fast k rel data sets violated the normality assumption (P<0.05) and were logarithmically transformed resulting in data sets not violating the normality assumption. 95% confidence intervals regarding each significant difference are provided in Supplementary Table 3 . Figure 4A shows the maximal tension (force normalized to CSA) of the entire R403Q group compared to HCM smn which did not differ between the two patient groups. However, when the 3 patients were analyzed individually ( Figure 4B ), myofibril preparations of the R403Q(1) patient did show a significantly lower tension compared with the myofibril preparations of HCM smn and the other R403Q patients.
The rate constant of force development (k act ) was significantly higher in R403Q myofibrils compared with HCM smn (Table 2 and Figure 1G ). In addition, when the myofibril data were separated per patient (Table 2) , each individual patient showed a significantly higher k act compared with HCM smn . In addition, k act of R403Q(2) was significantly higher compared with the other R403Q samples ( Table 2) .
The fast component of relaxation (fast k rel ) on average was significantly increased in R403Q myofibrils compared to HCM smn (Table 2) . This difference was due to higher fast k rel of myofibrils from patient R403Q(3) ( Table 2 ). The slow component of relaxation (slow k rel ) was significantly higher in the myofibrils of all R403Q patients together ( Figure 1H, 4C ) and when taken individually compared to HCM smn ( Figure 4D ).
As slow k rel~gapp~T C (see Supplementary material), the average slow k rel values of the 3 R403Q patients and HCM smn patients ( Figure 4D ) should correspond to the maximal TC values ( Figure 2F) . A clear positive linear relationship is visible when the data of Figure 2F and Figure 4D are combined with TC as a function of slow k rel ( Figure 5 ). This does not only show that cross-bridge relaxation kinetics and cross-bridge energetics correlate, but the differences among the three R403Q patients are evident as well, suggesting that other factors than the R403Q mutation underlie the changes in sarcomere properties. Figure 6A shows representative cross-sections of HCM smn , R403Q(1), R403Q(2) and R403Q(3) tissue stained with WGA. CSA was significantly higher of R403Q cardiomyocytes compared to HCM smn cells. The higher cellular CSA was mostly attributed to R403Q(1) cardiomyocytes ( Figure 6B&C ). Figure 6D shows representative cross-sections of HCM smn , R403Q(1), R403Q(2) and R403Q(3) tissue stained with Picrosirius Red. The amount of fibrosis tended to be higher (P=0.06) in R403Q compared to HCM smn tissue, which was mostly due to the significantly higher percentage of fibrosis in the R403Q(3) sample ( Figure 6E&F ).
Histology
Fraction of mutated MYH7 mRNA
As the three R403Q patients revealed different cross-bridge kinetics and energetics we studied the amount of mutant MYH7 mRNA present in the tissue of these patients. Three RNA extractions per patient were performed. Interestingly, Figure 6G shows that R403Q(1) has significant lower amount of R403Q mRNA compared to both R403Q(2) and R403Q(3) (95% confidence intervals in Supplementary Table 4) , while TC and slow k rel were highest in this patient ( Figure 2F , 4D) 
Discussion
This is the first study in which cross-bridge kinetics are directly compared to cross-bridge energetics in cardiac samples from the same patients. Our measurements of ATPase activity during sarcomere contraction in multicellular strips revealed a significantly higher TC in R403Q compared to HCM smn . High TC correlated with a significantly higher apparent rate of cross-bridge detachment under isometric conditions (measured from the isometric relaxation rate of myofibrils). Interestingly, changes in cross-bridge kinetics and energetics were not the same in all three R403Q patients. Our study provides evidence that the R403Q MYH7 mutation decreases the economy of myocardial contraction at the level of the sarcomeres and may indeed represent one of the causal factors of cardiomyopathy in patients carrying the R403Q mutation.
Decrease in maximal force
The R403Q mutation is located in a surface loop of the myosin head domain that forms an actin-myosin interface. It has been called the cardiomyopathy loop 24 as mutations in this area are known for their detrimental consequences on the cross-bridge cycle and sarcomere function. In both multicellular muscle strips and myofibril preparations of HCM with the R403Q mutation maximal force tended to be lower compared to HCM smn (Figures 2A,B &  4B) . Decreased maximal force generating capacity was also reported in human skeletal R403Q muscle fibers 25, 26 and cardiac muscle fibers from transgenic rodents 27 compared to controls as well. Due to the R403Q mutation the cross-bridges leave the force generating states faster, which is supported by the findings of the present study by the enhanced relaxation kinetics, i.e. increase in g app ( Figure 4C&D ). This should lead to a decline in force generating capacity of the sarcomere 5, 6 unless the increase in g app is compensated by an increase in f app . Kinetic data in Table 2 and Figure 4D support the idea that the R403Q mutation does increase f app besides increasing g app blunting the potential impact on force generation of the increased cross-bridge detachment rate (see Supplementary material Figure 1A&B ). In contrast to the multicellular preparations ( Figure 2B ), in myofibril preparations the force reduction was only seen in R403Q(1) ( Figure 4B ). This is in line with the larger effects on slow k rel , hence g app , in this patient compared with R403Q(2) and R403Q(3) ( Figure 4D ). In R403Q(2) and R403Q(3) the increase in g app is not that large and its effect on maximal force is compensated by the increase in f app (Supplementary material Figure 1A&B ). In multicellular preparations other than myofibril preparations, cellular remodeling like cellular hypertrophy, a lower myofibrillar density and fibrosis may also contribute to the reduced force generation (Figure 2A ). Indeed, a decrease in myofibrillar density has previously been correlated with the maximal force generating capacity in single human HCM cardiomyocytes with MYH7 mutations. 22, 28 . In the present study we show that cellular hypertrophy ( Figure 6B ) and the extent of fibrosis ( Figure 6E ) are higher in the R403Q group compared to the HCM smn. Cellular hypertrophy was highest in the R403Q(1) myectomy sample, which showed the lowest force generating capacity in muscle strips ( Figure 2B ), while fibrosis was most prominent in the R403Q(3) sample which was obtained during heart transplantations surgery from an end-stage failing patient. A combination of cellular remodeling and faster g app could explain the large decline in force in muscle strips of R403Q(1), while remodeling (i.e. fibrosis) seems to be the major determinant of reduced maximal force generation in R403Q(2) and R403Q(3) muscle strips. Another pathomechanism that may underlie reduced force generating capacity and warrants further research, may be protein modifications caused by oxidative stress such as actin carbonylation. Actin carbonylation was found to be increased in human end-stage heart failure tissue. 29 Interestingly, actin carbonylation was slightly higher in MYH7 mut tissue compared with HCM smn and significantly higher compared with non-failing donor tissue.
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Increased relaxation kinetics underlie higher tension cost
A significantly higher TC at maximal [Ca 2+ ] was found in multicellular muscle strips of 3 HCM patients harboring the R403Q mutation compared to muscle strips from HCM smn patients ( Figure 2E&F ). The same increase in TC was seen at submaximal [Ca 2+ ] illustrated by the steeper ATPase activity-tension relations of R403Q muscle strips compared to HCM smn ( Figure 3) . Overall, our data indicate that the R403Q mutation lowers economy of cardiac muscle contraction at the level of the sarcomere at maximal and submaximal (physiological) [Ca 2+ ].
This study directly shows, in agreement with previous studies, that slow k rel is equal to g app and energetic cost of tension development (Supplementary material) 6,10,11 as in addition to an approximately 80% increase in TC, we found an approximately 67% higher slow k rel of human R403Q myofibrils compared to HCM smn ( Figures 2&4) . Moreover, the increase in slow k rel for the three patients with R403Q correlated very well with the respective increase in TC ( Figure 5 ). Our data provide evidence that an increase in crossbridge detachment rate enhances the energetic costs of sarcomere contraction in human HCM with the R403Q mutation.
R403Q leads to a loss of function
Over the years extensive research has been performed on the functional consequences of the R403Q mutation. In vitro actin sliding velocity (V actin ) and ATPase assays were used to analyze the effects of mutation R403Q on cross-bridge mechanics and enzymatic properties of human skeletal muscle 31, 32 and human cardiac muscle expressing the mutant protein 5, [31] [32] [33] [34] , or on recombinant proteins/transgenic animal models. [35] [36] [37] [38] [39] It appears that the use of different models leads to a variety of outcomes regarding the functional consequences of the R403Q mutation of which an overview is provided in Supporting Material Table 5 . Specifically, the results obtained in rodents regarding the effects of the R403Q mutation cannot directly be extrapolated to the human situation as rodents express mostly the α-MyHC in the ventricles compared to mostly β-MyHC in human ventricles. 40, 41 Studies using transgenic R403Q mice with either an α-MyHC or a β-MyHC background revealed increased V actin , actin-activated ATPase activity and MgADP release rate in case of the α-MyHC background. However, expressing the R403Q mutation in β-MyHC background mice did not enhance any of the three parameters 42, 43 , showing the impact of the specific MyHC background on the mechanical and enzymatical properties. An in vitro motility study using human cardiac tissue showed an increased V actin . 33 Single molecule analyses revealed that the increase in V actin of human R403Q β-MyHC S1 was due to the lower time-period that the myosin head was connected to actin (t on ) without changes in unitary step displacement (d) of the myosin head suggesting that the R403Q mutation leads to destabilization of the actin-myosin interaction, hence to a more rapid myosin detachment. 33 In a previous 5 and in the present study faster relaxation kinetics from isometric steady state force generation and thus an increase in g app was found in myofibril preparations of human cardiac R403Q tissue. Overall it appears that the R403Q mutation leads to faster cross-bridge kinetics in combination with an overall loss of function characterized by decreased force production by the cross-bridges and reduced economy of contraction.
Expression of R403Q and sarcomere changes
MYH7 mutations usually are heterozygous, producing both an affected and unaffected allele resulting in poison peptides which are incorporated in the sarcomere. [44] [45] [46] Therefore, both healthy and mutated myosin proteins are present in the sarcomere. Analysis of R403Q mRNA revealed an almost 50% expression of the mutant in the two samples which were obtained during heart transplantation surgery, while mRNA expression level of R403Q was significantly lower in the sample (R403Q (1)) obtained during myectomy surgery ( Figure 6 ). Previously, Tripathi and co-workers 19, 47 revealed that heterozygous MYH7 mutations are subject to allelic imbalance, and mRNA and protein levels of mutant myosin correlated with HCM disease severity. Allelic imbalance due to cis-effects leading to different allelic expression of each parental chromosome was previously discovered in humans and not only linked to physiological differences between humans but also to the severity of diseases. 48, 49 Our data on mRNA expression support these previous studies and suggest that expression of mutant mRNA is higher at a more severe stage of cardiac disease, i.e. may increase during HCM development to end-stage heart failure. The question remains, however, why both slow k rel and TC differed among the individual R403Q patients. While the fraction of R403Q mRNA was lowest in R403Q(1) compared to both end-stage failing samples ( Figure 5A ), the R403Q(1) heart tissue showed the highest slow k rel and TC values. The fraction of mutated mRNA therefore did not explain the differences found in kinetics and energetics in the individual R403Q patients. We cannot exclude that the protein levels of the mutant protein do not correspond with the observed mRNA levels. However, a previous study 19 showed similar expression of several mutants at both mRNA and protein level determined in the both cardiac and skeletal muscle tissue. The influence of modifier genes, other than the causal mutated gene, could be a likely candidate as well. Modifier genes have been associated with differences in severity, penetrance and age of onset of HCM disease between patients with the same mutation or even from the same family. 50, 51 This could be of potential interest in case of R403Q (1) as this patient underwent a myectomy surgery already at age 25. Indeed, when age was correlated with TC and slow k rel (Supplementary material Figure 2A&B ) a correlation was present between age and TC (P=0.03; R 2 =0.51), which can clearly not be due to HCM smn as the correlation disappeared when the R403Q patients were excluded (P=0.6; R 2 =0.09). There was no significant correlation for slow k rel and age (P=0.23; R 2 =0.33) for the entire group. However, when the HCM smn group was excluded there tended to be a correlation (P=0.06; R 2 =0.71).
Interestingly, single myofibril measurements in a large number of non-failing donors and aortic stenosis patients do not show any effect of age on slow k rel either (author's unpublished results). Although the groups are too small to draw definite conclusions, based on the present data is seems that the influence of the R403Q mutation on function might be age-dependent and clearly requires future research.
Conclusion
We investigated the direct influence of the MYH7 mutation R403Q on the economy of sarcomere contraction using cardiac muscle from 3 HCM patients. For comparison we used tissue of HCM patients with a similar clinical phenotype without a sarcomeric gene mutation after thoroughly screening 9 genes. Our data show that the presence of a sarcomeric gene mutation is an important determinant of myocardial energy utilization. Our study shows faster cross-bridge kinetics and a direct increase in energetic costs of tension generation of sarcomeres harboring the R403Q MYH7 mutation compared to HCM smn sarcomeres. This indicates that the presence of the R403Q mutation can perturb sarcomere energetics which may reflect one factor causing HCM disease.
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Supplementary material Derivation of g app ≈ tension cost
Tension cost (TC) at the level of the cross-bridge represents the amount of ATP hydrolyzed by the myosin ATPase to generate a certain amount of isometric force (TC = ATPase/Force).
In which n is the number of turning-over cross-bridges per half sarcomere, b is the number of half sarcomeres, F is the mean force produced by a cross-bridge in the force-generating states (f app ) 6 Therefore app app app app
Assuming that length and cross-section of the muscle strip are taken into account (and thus n and b are taken into account) and that 
